Case Study · GLP-1 Support & Nutrition · Impact

Locked out of every ad platform in the fastest-growing category in health.

Demand was compounding weekly and the brand was legally unable to advertise into any of it. The people who could reach that audience were not on any marketplace — so we went and found them, and built the channel to $104.9k a month in seven.

$104.9k
Monthly sales at handover, from zero
$308,500
Sales driven across the managed period
$0
Paid media across the entire engagement
46%
Subscription attach on affiliate orders
The mandate

Acquisition where advertising is not available

SectorGLP-1 Support & Nutrition
MarketUS
PlatformImpact
ProgrammeUS
Engagement~7 months
Managed periodJan – Jul 2026
Sales driven$308k
Tracked orders1,836

Paid social and search are restricted for anything adjacent to GLP-1 medication. Ad accounts were being disapproved and landing pages flagged while category demand grew faster than the brand could legally address.

We were asked to build a channel that never depends on a platform's approval, and to make it durable enough to hand over.

The best partners in this category are patients. You will not find them in a media kit.

The result · managed period

A five-week legal hold flattens April, then two cohorts land at once

The April flat month is the category, not the programme.

$308,500
Sales driven
1,836 tracked orders
$104,900
Sales in final month
July 2026, at handover
$0
Paid media spend
Not a choice — the category is barred
46%
Subscription attach rate
On affiliate-sourced orders
$94 → $168
Average order value
Starter bundles, not price rises
~7 mo
Launch to handover
First sale January 2026

Monthly sales revenue — managed period (USD)

A five-week legal hold flattens April, then two cohorts land at once
$8k
$19k
$24k
$22k
$52k
$79k
$105k
JanFebMarAprMayJunJul
Discovery & repair phase
Month-on-month decline
Scaled
Blocked Meta, Google and TikTok, all category bans
April hold Five weeks, two largest publishers
Attach rate 46% of orders carry a subscription
Reading the curve
Jan – Mar
Recruitment through a medical-adjacent compliance framework. Every partner cleared individually, which is slow and is the reason the first quarter looks like this.
Apr
$21.7k, backwards on March. The two largest publishers pulled their content into legal review for five weeks. Nothing was wrong with the programme; the category simply moves at the speed of other people's lawyers.
May
Both publishers cleared in the same fortnight and the patient-community cohort came online together. The steepest month of the engagement by a distance.
Jun – Jul
Growth carried by subscription rather than new customers — 46% of affiliate orders now attach a subscription, so each month starts from a higher floor.

Figures cover the managed period only. Publisher legal review is a material and unpredictable variable in medically adjacent categories; the April flat month should be treated as a normal feature of this vertical rather than an anomaly.

The sequence

Teach the problem, then find the people living it

This category converts on explanation rather than on offers. The first partners had to be able to teach the problem credibly; the second wave were the people going through it. Both take far longer to recruit than a voucher site, which is the shape of the first quarter.

Phase 1 Foundation

Clinical and educational publishers

Health editorial, registered dietitian newsletters and comparison publishers, each taken through a medical-adjacent compliance framework agreed before launch. Traffic was routed into educational guides rather than product grids, which lifted conversion 52% against the homepage baseline.

Publisher categories cleared and activated
Health & clinical editorial Registered dietitian content Patient communities Comparison & review Email newsletters Sub-networks
118clinical, editorial and comparison publishers cleared and recruited.
52%conversion uplift from educational guides over product grids.
5 weeksthe longest single legal hold, on the two largest publishers.
Phase 2 The community pivot

The patient-community cohort

The highest-converting partners here are people documenting their own treatment. They have no rate card, no marketplace profile and no interest in a sponsorship. We found them inside the communities and onboarded them on commission alone.

  • Reply rates of 60-70% against 10-15% for conventional influencer outreach.
  • Every partner on commission-per-sale, no fixed fees anywhere in the programme.
  • Repeat purchase carried by the medication itself being taken continuously.
$83k
from patient-community creators. 27% of programme revenue, from 143 creators and community partners, essentially none of whom were reachable through paid channels or influencer marketplaces.

Where the revenue came from

Share of tracked sales across the managed period, by partner type

Health & clinical content
31%
Creators & patient communities
27%
Newsletter & email
15%
Comparison & review
13%
Sub-networks & technology
9%
Cashback & loyalty
5%
The handover

We grow it — then we hand you the keys

Our deal with every client is the same. We grow the programme, and when you're ready to bring it back in-house we give you the tools, the software and the support to run it yourself — without any drop in revenue. And we stay available, whenever your new account manager needs us.

01

The clearance framework

The medical-adjacent compliance pack and the per-publisher clearance process, which is what makes a serious health publisher willing to take the placement.

02

Community sourcing

Where the patient-community partners actually are, how to approach them and the terms that work when someone has never monetised before.

03

Held through a hold

We stayed on hand for the next legal review, because there is always a next one and it always lands at an inconvenient time.

What the client walked away with

  • A programme at $104.9k a month at handover, built with no advertising available.
  • 168 of 540 recruited publishers actively producing in a restricted category.
  • A partner base reachable through no paid channel whatsoever.
  • Subscription attach at 46%, so revenue carries forward month to month.
  • A compliance framework that survived a five-week publisher legal hold intact.
The bottom line

Zero to $104.9k a month with every major ad platform closed to them.

$308,500 in sales · 1,836 orders · 371k clicks · 31% active partners

The takeaway

When the two biggest platforms in the world refuse your money, this stops being a growth channel and starts being the business.

You came here to grow your program. Let's start with the revenue it's already leaking.

I've spent 28 years in affiliate, and almost every program leaks in the same places. I'll audit yours and hand you a plain, prioritised task list: exactly what to fix first and grow next. Free, and yours to keep forever. No card, no catch. Brands who work the list week to week see up to a 20% lift in traffic in 6 to 8 weeks. Imagine where that puts you in six months.

Free forever · yours to keep whether you hire me or not · about two minutes to start

About this case study. It describes a real GLP-1 companion nutrition programme managed by Affiliate Marketing Express. The client is anonymised for confidentiality. Nothing here constitutes medical guidance or a claim about GLP-1 medication. Individual results vary by programme size, category and market.